These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8790488)

  • 21. Fragile X disease.
    Biancalana V; Macpherson J
    Methods Mol Med; 2004; 92():157-82. PubMed ID: 14733312
    [No Abstract]   [Full Text] [Related]  

  • 22. A methylation PCR approach for detection of fragile X syndrome.
    Panagopoulos I; Lassen C; Kristoffersson U; Aman P
    Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apparent FMR1 allele instability in non-fragile X males.
    Brown WT; Nolin SL
    Genet Test; 2000; 4(3):241-2. PubMed ID: 11142753
    [No Abstract]   [Full Text] [Related]  

  • 24. Screening for FMR1 mutations among the mentally retarded: prevalence of the fragile X syndrome in Spain.
    Millán JM; Martínez F; Cadroy A; Gandía J; Casquero M; Beneyto M; Badía L; Prieto F
    Clin Genet; 1999 Jul; 56(1):98-9. PubMed ID: 10466426
    [No Abstract]   [Full Text] [Related]  

  • 25. Fragile X trinucleotide repeats from a normal population in Rio de Janeiro, Brazil.
    Sucharov CC; Silva R; Rondinelli E; Moura-Neto RS
    Hereditas; 1999; 130(2):189-90. PubMed ID: 10480000
    [No Abstract]   [Full Text] [Related]  

  • 26. [Genetics of Fragile X syndrome and its prevention].
    Boué J; Simon-Bouy B
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(3):273-9. PubMed ID: 9265049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular diagnosis of fragile X syndrome and distribution of CGG repeats in the FMR-1 gene in Taiwanese.
    Wang YC; Li C; Lin ML; Lin WH; Li SY
    J Formos Med Assoc; 2000 May; 99(5):402-7. PubMed ID: 10870330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implication of screening for FMR1 and FMR2 gene mutation in individuals with nonspecific mental retardation in Taiwan.
    Tzeng CC; Tzeng PY; Sun HS; Chen RM; Lin SJ
    Diagn Mol Pathol; 2000 Jun; 9(2):75-80. PubMed ID: 10850542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular screening for fragile X syndrome in mentally handicapped children in Korea.
    Kwon SH; Lee KS; Hyun MC; Song KE; Kim JK
    J Korean Med Sci; 2001 Jun; 16(3):271-5. PubMed ID: 11410685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slight instability of a FMR-1 allele over three generations in a family from the general population.
    Abramowicz MJ; Parma J; Cochaux P
    Am J Med Genet; 1996 Aug; 64(2):268-9. PubMed ID: 8844062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of FMR1 trinucleotide repeat expansion mutations using Southern blot and PCR methodologies.
    Tarleton J
    Methods Mol Biol; 2003; 217():29-39. PubMed ID: 12491918
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics of childhood disorders: XI. Fragile X syndrome.
    Eliez S; Reiss AL
    J Am Acad Child Adolesc Psychiatry; 2000 Feb; 39(2):264-6. PubMed ID: 10673840
    [No Abstract]   [Full Text] [Related]  

  • 34. Detection of X chromosome aneuploidy using Southern blot analysis during routine population-based screening for fragile X syndrome.
    Adir V; Shahak E; Dar H; Borochowitz ZU
    Genet Test; 2003; 7(4):345-6. PubMed ID: 15000814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A fragile balance: FMR1 expression levels.
    Oostra BA; Willemsen R
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R249-57. PubMed ID: 12952862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for fragile X syndrome: information needs for health planners.
    Murray J; Cuckle H; Taylor G; Hewison J
    J Med Screen; 1997; 4(2):60-94. PubMed ID: 9275266
    [No Abstract]   [Full Text] [Related]  

  • 37. Fragile X syndrome carrier screening in the prenatal genetic counseling setting.
    Cronister A; DiMaio M; Mahoney MJ; Donnenfeld AE; Hallam S
    Genet Med; 2005 Apr; 7(4):246-50. PubMed ID: 15834242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FMRP detection assay for the diagnosis of the fragile X syndrome.
    Willemsen R; Oostra BA
    Am J Med Genet; 2000; 97(3):183-8. PubMed ID: 11449486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for the fragile X syndrome: the necessity of international guidelines for molecular genetics predictive testing in general.
    Fryns JP
    Genet Couns; 1995; 6(4):293-6. PubMed ID: 8775414
    [No Abstract]   [Full Text] [Related]  

  • 40. Accelerated prenatal diagnosis of fragile X syndrome by polymerase chain reaction restriction fragment detection.
    Dobkin C; Ding X; Li S; Houck G; Nolin SL; Glicksman A; Zhong N; Jenkins EC; Brown WT
    Am J Med Genet; 1999 Apr; 83(4):338-41. PubMed ID: 10208176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.